Current Report

-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HR/gbGalsjKxN01q/rLitY8AtrIw4LiJwdXxlUv99+i/mT5/XuJLZ3rWxE8Lz2ik iL8RrG2Ny/XXWTbUQPBuOA== 0001193125-05-186606.txt : 20050916 0001193125-05-186606.hdr.sgml : 20050916 20050916114550 ACCESSION NUMBER: 0001193125-05-186606 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050912 ITEM INFORMATION: Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers FILED AS OF DATE: 20050916 DATE AS OF CHANGE: 20050916 FILER: COMPANY DATA: COMPANY CONFORMED NAME: E MED FUTURE INC CENTRAL INDEX KEY: 0000894552 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 870485314 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 033-55254-36 FILM NUMBER: 051088192 BUSINESS ADDRESS: STREET 1: 794 MORRISON ROAD STREET 2: SUITE 911 CITY: COLUMBUS STATE: OH ZIP: 43230 BUSINESS PHONE: 8778551319 FORMER COMPANY: FORMER CONFORMED NAME: MICRO ECONOMICS INC DATE OF NAME CHANGE: 19940601 8-K 1 d8k.htm CURRENT REPORT Current Report

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report: September 12, 2005

(Date of earliest event reported)

E Med Future, Inc.

(Exact name of registrant as specified in its charter)

Nevada

033-55254-36

87-0485314

(State or other jurisdiction

of incorporation)

(Commission File Number)

(I.R.S. Employer

Identification No.)

794 Morrison Road, Suite 911

Columbus, Ohio

43230

(Address of principal executive offices)

(Zip Code)

(877) 855-1319

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 5.02. Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officer

At the request of the newly appointed members of the Board of Directors, D. Dane Donohue resigned as President, Chief Executive Officer and a director of E Med Future, Inc. (“E Med”) on September 12, 2005. Mr. Donohue is a co-founder of E Med and remains a significant stockholder. Looking forward, Mr. Donohue plans to vigorously participate in the global distribution of E Med’s flagship product “NeedleZap^®” through the company’s current distributor, Safe Medical Solutions, LLC. Donald Sullivan, who has served as E Med’s Chief Financial Officer since November 2004 and a director since July 2005, was immediately appointed interim Chief Executive Officer. The remaining Board members are actively searching for candidates to fill the vacancies caused by Mr. Donohue’s resignation.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


E MED FUTURE, INC.

By:		/s/ Donald Sullivan
		Donald Sullivan, Chief Executive Officer

Date: September 16, 2005

-----END PRIVACY-ENHANCED MESSAGE-----